ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664529 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664529; 2) Community: the network communities that were significantly associated with the response to NSC 664529; 3) Molecule: the relationships between components within communities and NSC 664529; 4) MDR: the compounds that were significantly associated with the NSC 664529.

NSC Compound Enrichment Correlation
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.0131142867047947 0.36588461
NSC 3053 Actinomycin D 0.0131142867047947 0.011016222
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.0131142867047947 -0.15283869
NSC 339578 Null 0.0131142867047947 0.30675284
NSC 352299 2-methylellpticinium 0.0131142867047947 -0.20610268
NSC 381866 BAFILOMYCIN DERIV. 0.0131142867047947 0.28427644
NSC 404027 Null 0.0131142867047947 0.3569639
NSC 44580 9H-Purin-2-amine, 6-[[(2-chlorophenyl)methyl]thio]-9-propyl- 0.0131142867047947 0.23515273
NSC 606698 Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt 0.0131142867047947 -0.013829282
NSC 626167 Aplidazole C . TFA 0.0131142867047947 0.15099373
Total:121  Current:45    [First] [Prev] [Next] [Last]